As a strategist and biomedical engineer, Angela
brings deep scientific and strategic expertise to her
brands. She has experience in a variety of
therapeutic categories and is passionate about the
pull-through of scientific, competitive, and customer
insights to solve business and marketing challenges.

Angela is currently the strategy lead for an
innovative BMS launch product within immunology.
She has also worked as the medical strategist on
AstraZeneca’s renal portfolio, leading her team to
provide scientific insights on 2 innovative products.
Her previous experience includes blockbuster product launches and rare disease portfolio work. She strongly believes in simplifying complex
scientific concepts to be meaningful, accessible, and
scalable across a variety of customer groups.

Angela received her MS and PhD in biomedical
engineering from Stony Brook University; her
dissertation research was focused primarily in
neurology and orthopedics. Angela also has an
MEng in biomedical engineering from Cornell
University and a BE in biomedical engineering from
Manipal University in India.